Related Experiment Video
Updated: Jul 4, 2026
05:58
Retinal Detachment Model in Rodents by Subretinal Injection of Sodium Hyaluronate
Published on: September 11, 2013
Recurrent serous macular detachment after topical ocular hypotensive medication
Eulogio Besada1, Diana Shechtman, Barry J Frauens
1Nova Southeastern University College of Optometry, Miami Beach Florida 33162, USA. ebesada@nova.edu
Clinical & Experimental Optometry
|June 10, 2008
Summary
Topical ocular hypotensive medications may cause recurrent Choroidal Stromal Melanoma Development (CSMD). Discontinuation of these medications led to CSMD resolution, suggesting a potential link requiring cautious patient monitoring.
Area of Science:
- Ophthalmology
- Medical Research
Background:
- Choroidal Stromal Melanoma Development (CSMD) is a rare ocular condition.
- Topical ocular hypotensive medications are commonly used to manage glaucoma and ocular hypertension.
Observation:
- A case of recurrent CSMD was observed in a patient undergoing treatment with topical ocular hypotensive medications.
- The CSMD resolved upon cessation of the prescribed ocular hypotensive therapy.
Findings:
- The study documents a potential association between topical ocular hypotensive medication use and CSMD recurrence.
- While other contributing factors cannot be definitively excluded, the temporal relationship suggests a possible link.
Implications:
- Patients with a history of CSMD or those using ocular hypotensive medications should be monitored for CSMD development or exacerbation.
- Further research is warranted to elucidate the precise relationship between ocular hypotensive agents and CSMD.
Related Concept Videos
01:25Glaucoma: Overview
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
01:27Diabetic Retinopathy
DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
01:23Ophthalmic Drug Delivery Systems
Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...
01:28Angle Closure Glaucoma: Treatment
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
01:27Open Angle Glaucoma: Treatment
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...